# Estrogen Therapy as Prevention in the Progression of Aneurysm (EPPA) Trial

> **NCT01895881** · PHASE2 · WITHDRAWN · sponsor: **Rush University Medical Center**

## Conditions studied

- Cerebral Aneurysm
- Menopause
- Treatment

## Interventions

- **DRUG:** Estradiol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01895881
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-04
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to Recruit Participants
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01895881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01895881, "Estrogen Therapy as Prevention in the Progression of Aneurysm (EPPA) Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01895881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*